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In the last two decades new diseases and tumors have been described and it is now 
recognized that the same disease may be represented by different pathologic patterns. New 
biologic principles have helped to explain the pathogenesis of disease and new methods, such 
as immunofluorescence, ultrastructure, and biochemistry, are now available to the der-
matopathologist who must use them in addition to cytology, dark-field and polarizing 
microscopy, and histochemistry. 
For the past 75 years, dermatopathology has 
been the foundation upon which the specialty of 
dermatology has been built. The growing knowl-
edge acquired from clinicopathologic relationships 
is currently engendering a new vigor and excite-
ment. Every year new diseases are being identified 
from this extension of pathologic, immunologic, 
biochemical, and clinical knowledge . Table I con-
tains a partial list of these new diseases, which 
serves to demonstrate the results of the collabora-
tive efforts of several disciplines . In the definition 
of the Wiskott-Aldrich syndrome and ataxia telan-
giectasia, genetic and immunologic data were most 
important; in chronic granulomatous disease, im-
munology and biochemistry were most important 
in the descriptions of the hexosemonophosphate-
shunt defect and the failure of peroxide formation 
in the leukocyte. Equally important were the 
microbiologic methods which played a role in the 
discovery of the necrolytic staphylococcal toxin of 
group 2 staphylococci that focused attention on the 
two forms of toxic epidermal necrolysis. 
Tumor pathology is expanding, technically and 
diagnostically. Half of the forms of tumor differen-
tiation recognized in the past 20 years represent 
problems of pseudomalignancy: juvenile mela-
noma and keratoacanthoma, atypical fibroxan-
thoma, nodular faciitis , proliferative myositis, 
inflammatory angioendothelioma, eruptive histio-
cytoma, florid papillomatosis, and lymphomatoid 
papulosis , to mention only a few . New tumors and 
diseases are also being defined. For example, 
eccrine epithelioma, with its characteristic slow 
growth , location on the scalp, multiple local recur-
rences, and structural, histochemical, and electron 
microscopic features of eccrine tissue, has been 
shown to be a distinctive tumor [1], 5 cases of 
which have now been reported [2]. Basal cell 
carcinomas with every kind of epithelial and ap-
pendageal differentiation have been reported. 
The multifaceted epithelial cells, with their 
ability to form many epithelial structures and to 
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differentiate into mucous membrane, feather, cal-
lus, and cornea, have served as a basis for the study 
of tumor differentiation. Breathnach [3] has shown 
in embryonic skin that desmosomes appear 
before tonofilaments. Ciliated epidermis was 
demonstrated during intrauterine life and cilia 
were found on the individual epithelial cells; both 
hel ped us to understand such skin tumors as 
syringocystadenoma papilliferum or basal cell car-
cinoma cells with cilia . The interdependence of 
dermis and epidermis in the development of ap-
pendages shown by Sengel [4] was carried forward 
by Van Scott and Reinertson [5] who demon-
strated the dependence of basal cell carcinoma on 
its stroma. To Pinkus [6] we owe the description of 
the fibroepithelioma, in which the stroma is more 
prominent than the basal cell tumor. Many factors 
have been recognized to affect morphogenesis in 
skin. Included are epidermal growth factors, tem-
perature, prostaglandins [7,8], and genetic influ-
ences as is illustrated by 'xeroderma pigmentosum, 
in which multiple enzyme defects affect epidermal 
structure, tumor formation, and finally, individual 
survival [9] . 
EPIDERMAL PATHOLOGY 
The kinetics of some rapidly dividing epidermal 
cell populations have been studied. The turnover 
time and mitotic rate of the cells of the psoriatic 
epidermis have been estimated by many authors 
[10,11]. The rapid loss of cells is related to faulty 
keratinization and rapid cell reproduction which 
produce the downward growth of the epidermis 
and elongation of the rete ridges in psoriasis. When 
cells are not shed, the mass increases . But there is 
a limit to this increase, which is halted by apopto-
sis, a form of cell-to-cell digestion [12]. Keratino-
cytes have been observed to engulf Langerhans 
cells and other keratinocytes. In such tumors as 
basal cell carcinoma, apoptosis maintains tumor 
size and growth at a set rate; it also leads to cystic 
or differentiated changes in epithelial masses [13]. 
Epidermis responds to growth stimuli by extend-
ing itself along or about a stromal mass . This is 
observed in epithelial cyst production when frag-
ments of epidermis are placed free in the dermis, 
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TABLE 1. New diseases of the skin 
Balnei granuloma 
Zirconium granuloma 
Chronic granulomatous disease 
Protothecosis 
Facial granuloma 
Livedoid vasculitis 
Lymphomatoid granulomatosis 
Malignant atrophic papulosis 
Lupus panniculitis 
Lamellar ichthyosis 
Papular acantholysis 
Epidermal necrolysis 
Elastosis perforans 
Ataxia -telangiectasia 
Erythropoietic protoporphyria 
Focal dermal hypoplasia 
Wiskott-Aldrich syndrome 
N ormolipemic plane xanthoma 
Follicular mucinosis 
and in the phenomenon of epiboly, in which the 
epithelium of an organ culture spreads to surround 
the underlying dermis. The epithelial phenome-
non, known as epithelial segregation, occurs in 
verruca when the peripheral normal epithelium 
elongates and begins to grow towards the base of 
the verruca; in pyogenic granuloma, in which the 
lesion not only grows outward but is enclosed by 
the epithelium, moved to the surface, and pinched 
off; in elastosis perforans, where typically "perfora-
tion," the least important clinical and histologic 
quality, was used to describe a connective tissue 
degeneration. Mehregan, Schwartz, and Livingood 
[14] subsequently described "perforating" col-
lagenosis, and many cases of "perforating" granu-
loma annulare show that this is a general principle 
of epithelial behavior not confined to connective 
tissue or to granulomatous and inflammatory 
changes. Benign tumors, such as nevi [15], undergo 
involution and transepidermal loss by this phe-
nomenon. Basal cell carcinoma may be shed by this 
means, and the malignant mass of a melanoma 
may be eliminated in this way [16]. 
The symbiosis of epithelial cells and melano-
cytes has long been accepted, and normallympho-
cytes were recognized in the epidermis by Andrew 
and Andrew [17]. The recognition of the Langer-
hans cell as a part of the epithelial mass has 
reawakened interest in other epithelial cellular 
~;ymbionts. Langerhans cells are less phagocytic for 
"oreign particles than epithelial cells, are missing 
. n the rapidly proliferating epithelium of psoriasis, 
: )ut are found in lymph nodes and the thymus. 
:'hey appear in the dermis and dermal blood ves-
: els in dermatitis, in which they are often related to 
'f'mphocytes [18]. Merkel cells are characterized 
")y the presence of small, cytoplasmic, membrane-
iound granules and the absence of desmosomes, 
"ieural connections, and a rodlet nuclear inclusion 
"19]. The epidermis also contains indeterminate 
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cells, dendritic cells without characteristic organ-
elles, which most authors consider maturing Lan-
gerhans cells. 
There is intercellular space in the epidermis 
occupied by dendritic cells of various types and 
some lymphocytes. When melanocytes are de-
stroyed, as in vitiligo, other cells such as Langer-
hans cells move in to occupy it. When Langerhans 
cells disappear in psoriasis and verruca vulgaris, 
macrophages, lymphocytes, and ultimately poly-
morphonuclear leukocytes enter the epidermis. In 
a rapidly proliferating epithelium such as normal 
gingiva, white blood cells are frequently found. It is 
not uncommon to find mast cells in gingival 
epithelium, in pemphigus vegetans, and in such 
infectious acanthomas as blastomycosis. Epider-
motropism is apparent with the infiltrating lym-
phocytes at the dermoepidermal junction in para-
psoriasis, the infiltration of larger hyperchromatic 
cells in mycosis fungoides, histiocytosis X, histio-
cytic lymphoma, and in the nests of nevus cells in 
the nevus cell nevus, lentigo maligna, and the 
malignant melanoma. Pinkus and Mehregan [20] 
described malignant epidermotropic eccrine gland 
carcinomas, and Paget's disease represents the 
epidermotropism of malignant cells of various 
glandular and cellular origins. 
INFLAMMATION 
Our understanding of the pathology of inflam-
mation has been altered by the recognition that 
inflammatory mediators are correlated with vari-
ous phases of vascular and cellular inflammatory 
response. The early venous and mast cell responses 
are associated with histamine release, the late ones 
with peptides such as kin ins, and the delayed ones 
with lysosomal enzymes and prostaglandins [21). 
Recognition of the lysosome and of its role in 
phagocytosis enabled us to extrapolate to granulo-
matous inflammatory diseases such as granuloma 
annulare. This disease is characterized by a typical 
palisading pattern of acid phosphatase and other 
lysosomal enzymes in the histiocytes of the lesion. 
Lysosomal enzymes appear in the epidermis after 
ultraviolet light exposure or thermal burn and 
increase in the epidermis of lamellar ichthyosis. 
The mediators of inflammation such as hista-
mine, serotonin, catecholamines, acetykholine, 
prostaglandin, and peptides, are also major factors 
in the growth and development of cells. Receptors 
for these mediators are found in leukocytes, flbro-
blasts, mast cells, smooth muscle cells, endothelial 
cells, and epithelial cells. The mediators are re-
leased during inflammation, and their action on 
intact cells constitutes a major portion of the 
inflammatory reaction [22). Additional amine, 
peptide, or lipid mediators or receptors for them in 
the skin have yet to be described and the H2 
receptor needs to be explored. Chemotactic factors 
of epidermal, dermal, and circulatory origin can 
cause white blood cells to migrate and become 
immobilized. Eosinophilotactic factor can be gen-
erated from serum [23] and from mast cells [24]. 
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A major change in pathology has been the 
recognition that responses may vary in a given 
disease or from a given cause. We have stopped 
teaching "one histologic picture, one disease." For 
example, in benign lymphoproliferative disease of 
the skin, the clinical forms of lymphocytic dermal 
reticulosis (e.g., tick pseudolymphoma and Sezary 
syndrome) develop from delayed hypersensitivity. 
The process can be papular nodular, plaque-form-
ing, inflammatory, atrophic, or erythrodermic, as 
well as focal angiocentric or appendagocentric, 
bandlike, or infiltrative. The infiltrate is predomi-
nantly of T -lymphocytes [25]. All these processes 
are chronic, respond to x-ray therapy or penicillin, 
and evolve to lymphoma in some cases. Variations 
in clinical and histologic expressions can also be 
seen in histiocytosis X or mycosis fungoides (Tab. 
IT). By emphasizing the variation in histologic 
pattern, both the clinician and the pathologist can 
accommodate the extreme clinicopathologic varia-
bility to an individual case. 
HISTOCHEMICAL PATHOLOGY 
Mucin or mucopolysaccharides in myxedema, 
iron in hemochromatosis, fat in xanthoma, and 
calcium in pseudoxanthoma elasticum are demon-
strated by routine diagnostic methods. Other his-
tologic methods are available to demonstrate nu-
cleic acids, glycogen, sulfur-containing proteins, 
special amino acids such as tryptophan, histidine, 
and citrulline, and ions such as zinc. 
Techniques for studying respiratory, glycolytic, 
and lysosomal enzymes have yielded general 
information about tissue changes, but enzymatic 
procedures related to cell differentiation offer a 
clearer means of recognizing cell populations. For 
example, dopa-oxidase, studied by Bloch and de-
veloped by Fitzpatrick and Kukita [26] into a 
useful tyrosinase reaction, characterizes melano-
cytes and most pigmented tissue. The formalde-
hyde fluorescent method reveals dopamine in the 
TABLE II. Clinicopathologic correlation 
Disease 
Mycosis fungoides 
Histiocytosis X 
Histopathology 
Nonspecific dermatitis 
Neurodermatitis 
Psoriasiform 
Lichenoid 
P:uapsoriasis 
Follicular mucinosis 
Typical 
Atypical cellular infiltrate 
Intraepidermallymphoma 
Lymphoma 
Eosinophilic granuloma 
Histiocytosis 
Xanthoma 
Juvenile xanthogranuloma 
Reticulohistiocytoma cutis 
Reticulum cell sarcoma 
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same tissues [27] and can be used to characterize 
the tumors of pigment tissue. 
Histochemical cellular reactions may be used to 
characterize the tumor growths developing from 
certain cells. Amylophosphorylase is found in the 
external root sheath of the hair follicle, acanthotic 
epidermis, and the arrectores pilorum muscle, but 
it is particularly intense in sweat ducts and the 
eccrine secretory coil. Appendageal tumors with 
eccrine differentiation may be characterized by 
phosphorylase, as hidrocystoma, poroma, der-
mal duct tumor, syringoma, and solid and cystic 
hidradenoma [28] . The so-called eccrine spirade-
noma, a basaloid tumor arising from deep eccrine 
structures, does not have the enzyme or the ultra-
structure of eccrine glands. Apocrine tumors do not 
have phosphorylase. Low levels of respiratory, 
lysosomal, glycolytic, and special enzymes charac-
terize the basal cell hamartoma group of tumors 
(basal cell nevus, trichoepithelioma, cylindroma, 
and spiradenoma) . The differentiated form of 
trichoepithelioma develops small dermal papillary 
masses that are structurally and chemically typi-
cal of hair follicle papillae and contain polysac-
charide and alkaline phosphatase. 
Distinctions between types of spindle cell neo-
plasm can be aided by histochemistry [29]. Cholin-
esterase, found in peripheral nerves and end or-
gans, is also observed in neurofibromas. Nucleo-
side triphosphatase can be found in subepidermal 
nerve fibers and also in nerve tumors. Leiomyomas 
contain glycogen, phosphorylase, and muscle nu-
cleoside triphosphatase, and mesenchymal, fibro-
blastic, and histiocytic tumors may contain fat, 
lysosomal enzymes, and peptidase. 
ULTRASTRUCTURAL PATHOLOGY 
The electron microscope is a fundamental tool 
in experimental pathology [30], and the descrip-
tions of the cells and organelles of the epidermis 
and dermis provide a catalog that can be used to 
examine pathologic tissue. Table lIT gives the 
characteristic organelles that can be found in 
cutaneous cells and can be used to define patho-
logic changes. 
Melanosomes differ in size, shape, and packag-
ing according to genetic relations. Nonpigmented 
melanosomes, which can be recognized in the 
melanocyte of the albino, distinguish albinism from 
piebaldism and generalized vitiligo l31], and are 
diagnostic of amelanotic melanoma. Melanosomes 
have been observed in clear cell sarcomas of tendon 
sheaths [32,33] and in other pigmented cutaneous 
and neural tumors. 
When Langerhans granules were first observed 
in histiocytosis X, they were believed to be the 
viruses that caused the disease. These organelles 
are now used to define the lesions of histiocytosis X 
as tumors of Langerhans cells of mesenchymal 
origin. Juvenile xanthogranuloma does not contain 
such organelles [341 whereas xanthoma dis-
seminatum does. Reticulohistiocytoma cutis re-
cently described in neonates is also a syndrome 
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TABLE III. Cutaneous cells and their characteristic 
organelles 
Epidermal cell 
Melanocyte 
Langerhans' cell 
Merkel cell 
Endothelial cell 
Mast cell 
Apocrine cell 
Tonofilament 
Keratinosome 
Melanosome 
Langerhans' granule 
Membrane-bound granule 
Nuclear rodlet 
Tubular inclusion 
Lamellar, granular bodies 
Annulate lamellae 
with these organelles [35]; they are benign types of 
histiocytosis X in the newborn [36]. Gianotti and 
Caputo [37] found a vermiform cytoplasmic body 
in histiocytosis X. All histiocytic diseases contain 
bizarre, tubular membranous structures. Belcher, 
Czarnetzki, and Campbell [38] observed such 
tubular arrays in the lymphocytes of patients with 
sarcoidosis, and arciform tubular masses charac-
terize the cytoplasmic degeneration of glycolipid 
storage diseases. Lysosomes, containing acid phos-
phatase and other acid hydrolases, characterize all 
histiocytic, granulomatous, storage, and foreign-
body reactions. 
Normal skin in storage lipidoses, such as gangli-
osidoses, may show pathognomonic membranous 
cytoplasmic bodies in axons of cutaneous nerves 
[39], and marked vacuolization of endothelial, 
fibroblast, macrophage, and even Merkel cell cyto-
plasm. Ceroid lipofuscinoses show three types of 
cytoplasmic inclusions: membrane-bound curvi-
linear cytosomes, clumps of nonspecific granules, 
and amorphous osmiophilic deposits. The older 
patients with late-onset disease show fingerprint-
pattern membranous or tubular inclusions, which 
are diagnostic and are observed in the endothelial, 
Schwann, smooth muscle, appendage, and lym-
phocyte cell cytoplasm of all patients. Since no 
biochemical test for ceroid lipofuscinosis exists, 
electron microscopic examination of the skin bi-
opsy is diagnostic [40]. 
Another tubular array or network, associated 
with the endoplasmic reticulum of normal but not 
degenerative cells, has been described in the cyto-
plasm of endothelial, mesenchymal, and white 
blood cells of patients with lupus erythematosus 
[41] correlating with activity of the disease [42,43]. 
These structures, found in the normal skin cells of 
patients with systemic lupus erythematosus, may 
be increased by ultraviolet light [44]. Similar 
;nclusions are observed in the skin and blood cells 
·)f patients with dermatomyositis, Sjogren's syn-
drome, Degos' disease [45], and in nerve and 
·)lood cells in some myxoviral infections. 
Electron microscopic studies have clarified 
many functions of the fibroblast in producing 
'~ onnective tissue, elastin, mucopolysaccharide, 
md altered products such as in amyloid, lipoid 
;lroteinosis, and colloid milium, the production of 
such altered products as elastomucin which can 
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result in elastofibrosis dorsi, and the masses of 
small-diameter collagen fibers that characterize 
scleroderma [46]. In anetoderma, normal elastic 
tissue is absent and elastic microfibrils and thick-
ened epidermal basement membrane are formed. 
Cutis laxa and pseudoxanthoma elasticum are 
characterized by granular and calcified elastic 
fibers, respectively. Fibroblasts in juvenile fi-
bromatosis contain a large homogeneous cytoplas-
mic inclusion not found in other fibroblastic condi-
tions. 
The electron microscope has been useful in the 
study of Refsum's syndrome. Retinitis pigmentosa, 
ichthyosis, and nervous system degeneration are 
due to an enzymatic defect in alpha oxidation which 
leads to an accumulation of phytanic acid. Light 
microscopy fails to indicate any variation from 
autosomal dominant ichthyosis vulgaris, which the 
eruption clinically resembles. With electron mi-
croscopy, Refsum's syndrome shows normal kera-
tohyalin formation, and liposomes (presumably of 
cholesterol and phytanic acid) as well as giant 
mitochondria are present in the cytoplasm [47]. 
PATHOLOGIC CHANGES IN CLINICALLY 
NORMAL SKIN 
Pruritus may be the only abnormality when a 
biopsy specimen reveals lichen planus or mycosis 
fungoides. Normal-appearing skin may also reveal 
perivascular lymphocytic inflammation in diabet-
ics [48]. The demonstration of vascular hyaliniza-
tion in the normal skin of diabetics is characteris-
tic, as it is in lipoid proteinosis and erythropoietic 
proto porphyria. 
Studies of psoriatic blood vessels, their function 
and physiologic reaction to histamine and nicotin-
ate, indicate altered activity [49]. Epithelial pro-
liferation [50] and enzyme activity [51] are in-
creased in the normal skin of patients with psoria-
sis. Even at the surface, the ability to esterify 
cholesterol is reduced [52]. Recently, Cormane, 
Hanyadi, and Haemerlinck [53] demonstrated that 
the normal skin of psoriatic patients has circulat-
ing antibodies on the surface of the basal cells. 
Immunofluorescence studies of the normal skin 
of patients with dermatitis herpetiform is may 
show granular IgA and fibrin deposits. Similar 
studies of normal skin in cases of bullous pem-
phigoid sometimes reveal immunoglobulins and 
complement at the basement membrane adjacent 
to a bulla. Massive intravenous injections of anti-
body into rhesus monkeys by Sams and Gleich [54] 
resulted in epidermal localization of antibody but 
no clinical lesions. If antibodies can be localized in 
normal skin in these bullous diseases, it is not 
surprising that lesions appear in otherwise normal-
appearing skin or that trauma may induce lesions. 
The normal-appearing skin in Hailey-Hailey 
disease may show acantholysis (Fig.) which can be 
produced by ultraviolet light in the normal skin of 
such patients or their relatives, and in cases of 
pemphigus and pemphigoid [55]. 
Vascular immune complexes in both large and 
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FIG. Acantholysis in a biopsy of normal skin of a 
patient with Hailey-Hailey familial pemphigus 
(H & E; x 71). 
small blood vessels may be seen in normal skin. 
Schroeter, Conn, and Jordon [56] report immune 
complexes fixed in the vessels of normal skin of 
patients with the vasculitis of rheumatoid arthri-
tis. These vascular immunoglobulin and comple-
ment complexes are identical with those observed 
in the diseased, and at times also in normal, skin of 
patients with necrotizing and livedoid vasculitis 
[57]. Similar vascular immune complexes have 
been observed around the lesions of pyoderma 
gangrenosum in normal skin and may be involved 
in the cause and spread of the lesions. 
When the clinical signs are obvious, biopsy of 
normal skin sometimes reveals iron in hemo-
chromatosis, lipid or amyloid, inflammation, metal, 
or foreign material. Since the clinical appear-
ance of leprosy and similar infections may show 
little or no sign of disease , routine microscopic 
examination of preparations of apparently normal 
skin can show the disease. 
"NORMAL" PATHOLOGY OF THE SKIN 
Many abnormal states are brought about by 
changes which are normal reaction patterns but 
which have been accentuated, have occurred more 
rapidly, or have developed in unique locations. 
Pyogenic granuloma is an uncontrolled expression, 
probably elicited by some angiogenic factor, of 
capillary proliferation in inflammatory wound 
healing [58]. A similar reaction, the pseudoepi-
theliomatous hyperplasia found in chronic blasto-
mycotic or candidal infectons, might be called 
infectious acanthoma. The chronic lymphocytic 
and plasma cell dermal infiltrates of mucous 
membrane and skin are frequently related to the 
chronic antigenic stimulus of such infections [59]. 
No systematic studies of trichostasis spinulosa 
have been done in normal skin. Goldschmidt, 
Hojyo-Tomoka, and Kligman [60] observed an 
increase in trichostasis with age which is probably 
normal as is the Fordyce sebaceous change of 
mucous membranes. 
Verrucal changes over elbows, knees, knuckles, 
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and other extensor surfaces resemble epithelial 
nevi; as the areas become irritated, marked hyper-
keratosis occurs. Epidermolytic hyperkeratosis, 
originally believed to be characteristic of congeni-
tal ichthyosiform erythroderma, is now recognized 
as typical of all clinical forms of epithelial nevi-
localized, regional, linear, or universal [61]. Epi-
dermolytic histopathology is found in ichthyosis 
hystrix, linear nevus, white sponge nevus, kerato-
derma, and nevus comedonicus. Degos et al [62] 
believe that all epithelial nevi are similar; the fact 
that this pathology is related to such a variety of 
clinical keratodermas probably corroborates their 
view. More recently, epidermolytic hyperkeratosis 
has been observed in such isolated skin tumors as 
pilar cyst and seborrheic keratosis [63]. Shapiro 
and Baraf [64] described "epidermolytic" acan-
thoma as an isolated, tumor-like, epidermolytic 
acanthosis. All experienced dermatopathologists 
have observed this epidermolytic or acantholytic 
keratotic change in epidermis over inflammatory 
dermatoses and in foci of normal skin. In another 
acantholytic disease, familial benign chronic pem-
phigus or the Hailey-Hailey syndrome, the 
typical suprabasal acantholysis can be demon-
strated in clinically normal skin (Fig.). Trauma 
such as heat, cold, light, and friction can produce 
lesions in pemphigus, often in normal-appearing 
skin but usually in inflamed areas. 
The isolated myxoma represents fibroblastic 
production of acid mucopolysaccharide at the 
expense of its usual peptide products. Two other 
benign tumors, elastofibroma dorsi and granular 
cell schwannoma, represent tumor proliferations of 
a normal pathologic change. Granular cell tumors 
of apparent myogenic origin should probably be 
renamed granular cell schwannoma. These tumors 
are found in skin and mucous membranes, where 
they grow around the nerve trunks. 
The elastofibroma dorsi tumor was first de-
scribed as a solid mass beneath the scapulas of 
middle-aged women. In 1973, Reed and Bliss [65] 
demonstrated the pathology of Morton's neuroma 
and observed adjacent to it elastic tissue changes 
typical of elastofibrosis and possibly related to 
pathology of the bursa. They described this as 
"regressive and productive intermetatarsal elas-
tofibrosis." Jarvi and Lansimies [66] have recently 
reported on subclinical elastofibrosis in the scapu-
lar region of 235 autopsies. They found elastofi-
brotic changes in 39 cases, all in persons at least 58 
years old and in twice as many women as men. 
PERSPECTIVE 
Pathology is no longer the simple field of light 
microscopic examination of diseased tissue. The 
biochemical, immunologic, and other examina-
tions of the skin point in the directions of the rapid 
expansion of the field of pathology. Table IV lists 
the isolated systems that have been used for the 
study of biology of the skin. The application of 
these systems to the study of disease will provide a 
new frontier for pathology. The surface of the 
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TABLE IV. Isolated cutaneous systems 
Epidermis 
Stratum corneum 
Keratinocytes 
Basal cells 
Appendages 
Hair follicles 
Sebaceous gland 
Eccrine gland 
N onkeratinocytes 
Melanocytes 
Langerhans cells 
Dermis 
Fibroblast 
Arrectores pilorum 
Vascular smooth muscle 
Endothelial cell 
Adipocytes 
individual cell with its biochemical, immunologic, 
pharmacologic, and viral receptors is an additional 
area of new pathology, for these receptors are 
altered by genetic expression and in acquired 
disease. Scanning, freeze-fracture, and im-
munohistochemical methods of electron micros-
copy can be used to demonstrate the cell surface 
changes. The next 25 years will see pathology, 
though still based on clinical and microscopic 
analysis, utilizing all the methods of modern 
science to understand the diseases of the skin. 
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